Clinical trial
Seasonal Allergic Rhinitis In Pediatric Subjects
NCT00107757 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00107757 |
|---|---|
| Title | Seasonal Allergic Rhinitis In Pediatric Subjects |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 50mcg and 100mcg for 2 Weeks in Pediatric Subjects Ages 2 to <12 Years With Seasonal Allergic Rhinitis (SAR) |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rhinitis, Allergic, Perennial |
| Intervention type | Drug |
| Interventions | GW685698X |
| Enrollment | 576 |
| Start date | Mar 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Apr 8, 2005 |
| Last update posted | Sep 15, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: